BioSpace News Archive

Horizon Therapeutics plc (Nasdaq: HZNP) today announced record third-quarter 2021 financial results and increased both its full-year 2021 net sales and adjusted EBITDA guidance.

Agios Pharmaceuticals, Inc. today reported business highlights and financial results for the third quarter ended Sept. 30, 2021.

Oncolytics Biotech® Inc. today announced that the first patient has been dosed in the phase 1/2 GOBLET trial.

Following a successful $220 million Series C funding round, pioneering health information and devices company Exo is expanding its board of directors and adding key industry leaders to its management team to carry out its mission of taking medical imaging everywhere.

BrainCheck Raises $10 Million in Series B Funding to Transform Cognitive Health Assessment and Care for Alzheimer’s and Related Dementias

InflaRx announced today that Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will present a corporate overview during a fireside chat at the Credit Suisse 30th Annual Healthcare Conference.

Biogen Inc. announced the company will present a variety of new data from its Alzheimer’s disease product portfolio and clinical development pipeline at the upcoming annual Clinical Trials on Alzheimer’s Disease conference (CTAD), held November 9-12 virtually and in Boston, Massachusetts.

InMed Pharmaceuticals Inc today announced that it has filed an international patent application demonstrating neuroprotection and enhanced neuronal function using a rare cannabinoid for the potential treatment of neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease and others.

PharmaTher Holdings Ltd. is pleased to announce it has entered into a research collaboration agreement with Revive Therapeutics Ltd.

Otonomy, Inc. today announced it will report financial results for the third quarter 2021 and provide a corporate update at 4:30 p.m. ET (1:30 p.m. PT) on November 10, 2021.